Condition
Healthy Participants With Lower-than-average Mental Well-being
Total Trials
1
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
Treatment Research
3 treatments under study, led by Context 2
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Phase 2 (1)
Trial Status
Recruiting1
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Context 21
- Context 11
- Psilocybin1
Active Sponsors
- Robin Carhart-Harris, PhD, MA1
Top Investigators
University of California, San Francisco
University of California, San Francisco